Cointime

CARB-X

company

About

CARB-X is a biopharmaceutical business enterprise that specializes in biotechnology, antibiotics, vaccines, fast diagnostics.

  • 11 - 50

Highlights

Investments
3
Lead Investments
3

Details

Founded date
Jul 1, 2016
Number Of Employee
11 - 50
Operating Status
Active
Investor Type
Accelerate

Accelerate a diverse portfolio of at least 20 high-quality antibacterial products towards clinical development leveraging $250 million in BARDA funds with matching funds from the Wellcome Trust and the AMR Centre.

Investments

Number of Investments
Number of Lead Investments
3
3
CARB-X has made 3 investments. Their most recent investment was on Feb 1, 2021, when Avails Medical raised $2.50M.
Date Company Name
Round Money Raised Industry Lead Investor
Feb 1, 2021 Avails Medical
Grant $2.50M Health Care Yes
Aug 11, 2020 Evotec
Grant $2.91M Biopharma Yes
Oct 1, 2019 Trellis Bioscience
Grant $3.20M Biotechnology Yes
Cointime
เนื้อหา
บริษัท